caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1821195900

Laura Paoletti

PRACTICEDEPARTMENT OF MEDICINE MSGSee all providers at this practice →
Nurse PractitionerOswego, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Laura Paoletti's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Rahul Seth
Hematology-Oncology · Syracuse, NY
65410
Sam Benjamin
Medical Oncology · Syracuse, NY
2590
James Sherwood
Diagnostic Radiology · Syracuse, NY
1623
Padma Ram
Internal Medicine · Oswego, NY
1145
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
87.6
Quality
72.0
Cost
75.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
205
Beneficiaries
—
Total drug cost
$27K
Distinct drugs
7
Brand share
24.9%
Top prescribed drugs
Anastrozole97 claims
Hydroxyurea24 claims
Gabapentin21 claims
Rivaroxaban21 claims
Apixaban18 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.